Clinical features, pathogenesis and treatment of long-haul COVID‑19 impact on nervous system
- 28 March 2021
- journal article
- research article
- Published by Alfmed LLC in Medical alphabet
- No. 3,p. 14-22
Abstract
The current outbreak of coronavirus SARS-CoV‑2 (COVID-19) has raised great concern worldwide, but its impact on nervous system still needs more investigation. Thirty per cent of symptomatic patients with COVID‑19 will have symptoms that last longer than the typical two weeks, 10 % have symptoms longer than 3 months and this is called ‘long-COVID’. These symptoms affect not only people with severe disease, but also those with milder cases. Many long-haulers experience the same symptoms they had during their initial fight with COVID‑19, such as fatigue, cognitive impairment (or brain fog), difficulty breathing, headache, depression, insomnia and loss of the sense of taste and\or smell. Treatment of those complications with citicoline, ethylmethylhydroxypyridine succinate and vitamin B improves these symptoms in patients but most of them also need cognitive therapy for dehypochondrisation.Keywords
This publication has 19 references indexed in Scilit:
- Encephalitis as a clinical manifestation of COVID-19Brain, Behavior, and Immunity, 2020
- Nervous system involvement after infection with COVID-19 and other coronavirusesBrain, Behavior, and Immunity, 2020
- Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) PandemicStroke, 2020
- Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19Acta Physiologica, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Diabetic and non-diabetic neuropathies in patients with diabetes mellitusS.S. Korsakov Journal of Neurology and Psychiatry, 2018
- Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized ChildrenIntervirology, 2016
- The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectivesClinical Interventions in Aging, 2015
- Methods of investigation for cardiac autonomic dysfunction in human research studiesDiabetes/Metabolism Research and Reviews, 2011
- Diagnosis and management of diabetic autonomic neuropathy.BMJ, 1982